Talk to Robyn
(866) 682 9815
Search inside this page
Publication dates
Publishers
data types
Free Market Research Guides to Download
» Purchase Premium Reports
61-100 of about 700 reports
Yearly, From 2004 To 2011
By Business Monitor International
Source: BMI Espicom
Yearly, From January 01, 2011 To January 01, 2011
By Business Monitor International
Source: BMI Espicom
Yearly, From 2004 To 2011
By Business Monitor International
Source: BMI Espicom
Yearly, From 2004 To 2011
By Business Monitor International
Source: BMI Espicom
Yearly, From 2004 To 2011
By Business Monitor International
Source: BMI Espicom
Yearly, From 2003 To 2011
By Business Monitor International
Source: BMI Espicom
Yearly, From 2003 To 2011
By Business Monitor International
Source: BMI Espicom
Yearly, From 2003 To 2011
By Business Monitor International
Source: BMI Espicom
Yearly, From January 01, 2011 To January 01, 2011
By Business Monitor International
Source: BMI Espicom
Yearly, From 2003 To 2011
By Business Monitor International
Source: BMI Espicom
This new 800-page seven-country report from Venture Planning Group is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the global transfusion ...
Highlights This new 426-page market segmentation analysis of the transfusion testing market report from Venture Planning Group including: - Major issues pertaining to the Japanese transfusion testing ...
> Highlights This new 590-page analysis of the Japanese tumor marker testing market report from Venture Planning Group including: - Major issues pertaining to the Japanese laboratory practice, as well ...
This new 142-page report from Venture Planning Group presents a comprehensive analysis of the Japanese flow cytometry market, including: - Major issues pertaining to the Japanese flow cytometry practice, ...
This new report from Venture Planning Group contains 537 pages, 42 tables, and presents a comprehensive analysis of the Japanese hospital cancer diagnostics market, including: - Major issues pertaining ...
This new report from Venture Planning Group contains 891 pages, 75 tables, and presents a comprehensive analysis of the Japanese hospital infectious disease testing market, including: - Major issues pertaining ...
This new report from Venture Planning Group contains 650 pages, 150 tables and provides forecasts for 40 major procedures, as well as sales and market shares for reagent and instrument suppliers by country. ...
This new 198-page report from Venture Planning Group presents a detailed analysis of the APTT testing market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan, including clinical significance ...
This new 195-page report from Venture Planning Group presents a detailed analysis of the Alpha-2 Antiplasmin testing market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan, including clinical ...
This new 197-page report from Venture Planning Group presents a detailed analysis of the AT III testing market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan, including clinical significance ...
This new 197-page report from Venture Planning Group presents a detailed analysis of the D-Dimer testing market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan, including clinical significance ...
This new 295-page report from Venture Planning Group presents a detailed analysis of the Factor Assays testing market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan, including clinical ...
This new 200-page report from Venture Planning Group presents a detailed analysis of the Fibrinogen testing market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan, including clinical significance ...
This new 194-page report from Venture Planning Group presents a detailed analysis of the Proteins C and S testing market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan, including clinical ...
This new 200-page report from Venture Planning Group presents a detailed analysis of the Heparin testing market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan, including clinical significance ...
This new 196-page report from Venture Planning Group presents a detailed analysis of the Thrombin Time testing market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan, including clinical ...
This new 200-page report from Venture Planning Group presents a detailed analysis of the PT testing market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan, including clinical significance ...
This new report from Venture Planning Group contains 21 pages, 4 tables and provides an overview of the Japanese coagulation testing market, including sales and market shares of leading reagent and instrument ...
This new 243-page report from Venture Planning Group presents a detailed analysis of the ß-2 Microglobulin testing market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan, including clinical ...
This new 278-page report from Venture Planning Group presents a detailed analysis of the CA 15-3/27.29, CA 19-9, and CA 125 testing market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan, ...
This new 250-page report from Venture Planning Group presents a detailed analysis of the CEA testing market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan, including clinical significance ...
This new 242-page report from Venture Planning Group presents a detailed analysis of the PAP testing market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan, including clinical significance ...
This new 243-page report from Venture Planning Group presents a detailed analysis of the Occult Blood testing market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan, including clinical ...
This new 243-page report from Venture Planning Group presents a detailed analysis of the Pap Smear/HPV testing market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan, including clinical ...
This new 249-page report from Venture Planning Group presents a detailed analysis of the PSA testing market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan, including clinical significance ...
This new 288-page report from Venture Planning Group presents a detailed analysis of the AIDS diagnostics market in the US, Europe, (France, Germany, Italy, Spain, UK) and Japan. Current scientific views ...
This new 200-page report from Venture Planning Group presents a detailed analysis of the E. Coli diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific ...
This new 25-page report from Venture Planning Group provides an overview of the Japanese infectious disease diagnostics market, including market shares of leading suppliers by test, as well as volume ...
This new 288-page report from Venture Planning Group presents a detailed analysis of the AIDS diagnostics market in the US, Europe, (France, Germany, Italy, Spain, UK) and Japan. Current scientific views ...
This new 205-page report from Venture Planning Group presents a detailed analysis of the Adenovirus diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific ...
» Download Public Reports
90 reports
... Period of the previous year. x-ray ct systems regarding x-ray ct systems, service income decreased in both japan and overseas despite sales of 64-slice ct systems that exceeded the levels of the same ...
» Read our Company Profiles
30 CompaniesReportlinker.com © Copyright 2013. All rights reserved.